TacticScaleWhat Innospec Does & How It Makes Money (IOSP)
Updated October 2026 · reflects Innospec's latest reported financials
Specialty chemicals maker for fuels, personal care, and oilfield markets. Innospec earns revenue by making, blending, and selling specialty chemical products and technology-based formulations to industrial customers.
How Innospec makes money
Innospec earns revenue by making, blending, and selling specialty chemical products and technology-based formulations to industrial customers. Its customers include multinational consumer-goods makers, oil companies, fuel marketers, and oilfield operators, and sales are split across three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
What Innospec does
Innospec Inc. is a specialty chemicals company headquartered in Englewood, Colorado. Its roots go back to 1938, and it was known as Octel Corp. until it changed its name in January 2006. It develops, manufactures, blends, and supplies chemicals across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The business has three segments. Fuel Specialties sells additives used in diesel, jet, marine, and heating fuels to oil companies, fuel marketers, terminals, and marine lines. Performance Chemicals provides ingredients and technology-based formulations for personal care, home care, agrochemical, construction, and mining customers. Oilfield Services supplies chemicals for drilling, completion, and production, along with drag reducing agents, to exploration and production companies and oilfield service firms.
Products & services
- Fuel additives for diesel, jet, marine and heating fuels
- Performance chemicals for personal and home care
- Specialty chemicals for agrochemical, construction and mining markets
- Oilfield drilling, completion and production chemicals
- Drag reducing agents for oil and gas
What is Innospec worth?
On an owner-earnings DCF, Innospec's most-likely value is about $47 versus a recent price near $96 (51% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$28) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
NewMarket (NEU) · Innovex International (INVX) · Ingevity (NGVT) · Sinopec Shanghai Petrochemical (600688.SS) · Stepan (SCL)